Polymer engineered regenerating bioscavengers

US10400232B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10400232-B2
Application numberUS-201415026093-A
CountryUS
Kind codeB2
Filing dateOct 3, 2014
Priority dateOct 3, 2013
Publication dateSep 3, 2019
Grant dateSep 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the invention provide at least one polymer covalently conjugated to an esterase. The at least one polymer includes a plurality of oxime functional groups.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising: at least one polymer covalently conjugated to an enzyme, the at least one polymer comprising a reactive functional group, wherein the reactive functional group reacts with an inhibitor attached to an active site of the enzyme. 2. The composition of claim 1 , wherein the enzyme comprises an esterase, and the reactive functional group comprises a plurality of oxime functional groups. 3. The composition of claim 2 , wherein the esterase is selected from the group consisting of acetylcholinesterase and butyrylcholinesterase. 4. The composition of claim 2 , wherein the esterase comprises chymotrypsin. 5. The composition of claim 2 , wherein the plurality of oxime functional groups comprises alkyne derivatives of 2-pyridine aldoxime. 6. The composition of claim 2 , wherein the plurality of oxime functional groups comprises an aldoxime. 7. The composition of claim 2 , wherein the plurality of oxime functional groups comprises a ketoxime. 8. The composition of claim 1 , wherein the reactive functional group reacts with the inhibitor attached to the active site of the enzyme, thus releasing the inhibitor from the active site and restoring activity to the active site of the enzyme. 9. The composition of claim 1 , wherein the at least one polymer comprises at least one environmentally responsive monomer. 10. The composition of claim 1 , wherein the at least one polymer is a copolymer comprising at least two different monomers, wherein at least one monomer is selected from the group consisting of aldoximes, ketoximes, muco-adhesion monomers, polyethylene glycol, bis-pyridinium oximes, N,N-dimethylacrylamide, N-isopropylacrylamide, (meth)acrylate, N,N-dimethylaminoethyl methacrylate, carboxyl acrylamide, 2-hydroxylethylmethacrylate, N-(2-hydroxypropyl)methacrylamide, quaternary ammonium monomers, sulfobetain methacrylate, oligo(ethylene glycol) methyl ether methacrylate, 2-PAM monomers, 4-PAM monomers, Clickable azide monomers, and combinations thereof. 11. A composition comprising: a bioconjugate comprising: an enzyme; and at least one polymer covalently conjugated to the enzyme, wherein the at least one polymer comprises a plurality of reactive functional groups, and at least one reactive functional group of the plurality of reactive functional groups is positioned to react, in use, with a functional group on an inhibitor attached to an active site of the enzyme. 12. The composition of claim 11 , wherein the enzyme comprises an esterase, and the at least one reactive functional group comprises a plurality of oxime functional groups. 13. The composition of claim 12 , wherein the at least one reactive functional group comprises an oxime functional group positioned to exert a nucleophilic attack on a phosphoryl functional group of the inhibitor when the phosphoryl functional group is attached to the active site of the esterase, said nucleophilic attack resulting in removal of the phosphoryl functional group from the active site and restoration of activity to the esterase. 14. The composition of claim 12 , wherein the at least one polymer of the bioconjugate comprises a flexibility sufficient to react, in use, with a phosphoryl functional group of the inhibitor attached to the active site of the esterase. 15. The composition of claim 12 , wherein the at least one polymer covalently conjugated to the esterase forms a long lived covalent conjugate that is maintained in the body for a time period ranging from more than about one day to more than about one week. 16. The composition of claim 12 , wherein the at least one polymer is a co-polymer comprising at least two different monomers, wherein at least one monomer comprises a member selected from the group consisting of aldoximes, ketoximes, muco-adhesion monomers, polyethylene glycol, bis-pyridinium oximes, N,N-dimethylacrylamide, N-isopropylacrylamide, (meth)acrylate, N,N-dimethylaminoethyl methacrylate, carboxyl acrylamide, 2-hydroxylethylmethacrylate, N-(2-hydroxypropyl)methacrylamide, quaternary ammonium monomers, sulfobetain methacrylate, oligo(ethylene glycol) methyl ether methacrylate, 2-PAM monomers, 4-PAM monomers, Clickable azide monomers, and combinations thereof.

Assignees

Inventors

Classifications

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title

  • Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4) · CPC title

  • C12N9/96Primary

    Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates · CPC title

  • acting on ester bonds (3.1), e.g. lipases, ribonucleases · CPC title

  • Chymotrypsin (3.4.21.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10400232B2 cover?
Embodiments of the invention provide at least one polymer covalently conjugated to an esterase. The at least one polymer includes a plurality of oxime functional groups.
Who is the assignee on this patent?
Univ Carnegie Mellon
What technology area does this patent fall under?
Primary CPC classification C12N9/96. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).